Global Trust Asset Management, LLC Gilead Sciences, Inc. Transaction History

Global Trust Asset Management, LLC

$209 Million
Q3 2025

A detailed history of Global Trust Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 2,200 shares of GILD stock, worth $261,448. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,200

Previous 1,770 24.29%

Holding current value

$261,448

Previous $196,000 24.49%

% of portfolio

0.12%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 28, 2025	BUY	$108.22 - $120.47 $46,534 - $51,802	430 Added 24.29%	2,200 $244,000
Q2 2025 Jul 17, 2025	BUY	$96.91 - $113.0 $171,530 - $200,010	1,770 New	1,770 $196,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $4,860 - $6,978	-78 Reduced 11.0%	631 $54,000
Q3 2022 Oct 07, 2022	BUY	$59.54 - $68.01 $4,644 - $5,304	78 Added 12.36%	709 $44,000
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $9,004 - $10,141	-156 Reduced 19.82%	631 $39,000
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $33,023 - $37,482	-509 Reduced 39.27%	787 $57,000
Q2 2021 Jul 13, 2021	SELL	$63.47 - $69.35 $14,788 - $16,158	-233 Reduced 15.24%	1,296 $89,000
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $334,380 - $381,527	-5,573 Reduced 78.47%	1,529 $99,000
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $23,396 - $26,659	-413 Reduced 5.5%	7,102 $414,000
Q2 2020 Jul 08, 2020	SELL	$72.34 - $84.0 $607,583 - $705,516	-8,399 Reduced 52.78%	7,515 $578,000
Q1 2020 Apr 06, 2020	BUY	$62.63 - $80.22 $513,190 - $657,322	8,194 Added 106.14%	15,914 $1.21 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $59,586 - $65,543	-967 Reduced 11.13%	7,720 $502,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $27,441 - $30,291	-439 Reduced 4.81%	8,687 $551,000
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $17,694 - $19,842	-286 Reduced 3.04%	9,126 $617,000
Q1 2019 Apr 05, 2019	SELL	$62.53 - $70.05 $26,262 - $29,421	-420 Reduced 4.27%	9,412 $612,000
Q4 2018 Jan 11, 2019	SELL	$60.54 - $79.0 $50,248 - $65,570	-830 Reduced 7.78%	9,832 $615,000
Q3 2018 Oct 16, 2018	SELL	$71.28 - $78.92 $119,607 - $132,427	-1,678 Reduced 13.6%	10,662 $823,000
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $3,892 - $4,540	-60 Reduced 0.48%	12,340 $874,000
Q1 2018 Apr 26, 2018	SELL	$72.84 - $88.8 $9,105 - $11,100	-125 Reduced 1.0%	12,400 $935,000
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $891,153 - $1.05 Million	12,525	12,525 $897,000

Others Institutions Holding GILD

# of Institutions

2,362

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.11M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $149B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.

Account

Global Trust Asset Management, LLC Gilead Sciences, Inc. Transaction History